Creamer J E, Nathan A W, Camm A J
Br Heart J. 1985 Feb;53(2):164-6. doi: 10.1136/hrt.53.2.164.
Intravenous flecainide successfully terminated atrial tachycardia in three patients. Maintenance treatment with oral flecainide prevented the recurrence of tachycardia for up to three years. These results suggest an additional use for flecainide which should be further explored.
静脉注射氟卡尼成功地使3例患者的房性心动过速终止。口服氟卡尼维持治疗预防心动过速复发长达3年。这些结果提示氟卡尼有一项应进一步探索的新用途。